Primary Record
Neoeriocitrin
- In stock
- 2,920 g
- Purity
- 98.4 %
- CAS
- 13241-32-2
Compound Identifiers & Properties
- CAS
- 13241-32-2
- PubChem CID
- 114627
- SMILES
- C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)O)O)O)CO)O)O)O)O)O
- Canonical SMILES
- C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)c(O)c3)CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
Names & Synonyms
- Neoeriocitrin
- Isoeriocitrin
- 13241-32-2
- eriodictyol-7-neohesperidoside
- Eriodictyol 7-O-neohesperidoside
- AC1L3FPQ
- Eriocitrin Impurity 1
- Eriodictyol 7-neohesperidoside
- Neoeriocitrin (Standard)
- RefChem:165236
- GlyTouCan:G82933XM
- Eriodictyol-7-O-neohesperidoside
- CHEBI:7502
- SureCN7203878
- CHEMBL3609603
- DTXSID70157530
- MEGxp0_001062
- orb1297542
- SCHEMBL7203878
- DTXCID1080021
- Neoeriocitrin, ~95% (HPLC)
- SCHEMBL29366330
- 3-NITROBENZOYLACETONITRILE
- ACon1_000964
- CTK8G1789
- EINECS 236-215-3
- HY-N4119R
- C27H32O15
- MFCD32661901
- EX-A6775
- G82933XM
- HY-N4119
- MSK40164
- ZINC8234301
- AR-1I7187
- BDBM50597717
- CID114627
- AKOS037514509
- ACN-057276
- CID:114627
- EBC-616633
- FS-7651
- VA11372
- C27-H32-O15
- NCGC00169807-01
- OE137775
- SID:250230358
- J213.772K
- Neoeriocitrin, analytical reference material
- CS-0032132
- FT-0630400
- FT-0777482
- NS00024212
- C09805
- A806431
- C553460
- BRD-K49062828-001-01-6
- Q13564785
- (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-2,3-dihydrochromen-4-one
- B2703-067808
- (S)-7-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-2-(3,4-dihydroxyphenyl)-5-hydroxychroman-4-one
- (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-chroman-4-one
- (2S)-7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5-hydroxy-3,4-dihydro-2H-1-benzopyran-4-one
- Neoeriocitrineriodictyol-7-neohesperidoside; Eriodictyol 7-neohesperidoside
- 3',4',5,7-Tetrahydroxy-flavanone 7-[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranoside]
- (2S)-7-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl)oxy-tetrahydropyran-2-yl)oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-chroman-4-one
- (2S)-7-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl)oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-2,3-dihydrochromen-4-one
- (S)-3',4',5,7-Tetrahydroxyflavanone-7-[2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside]
- (S)-7-((2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-4H-benzopyran-4-one
- (S)-7-[[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-4H-1-benzopyran-4-one
- (S)-7-[[2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-4H-benzopyran-4-one
- 236-215-3
- 4113-94-4
- 4H-1-Benzopyran-4-one, 7-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (S)-
- 4H-1-Benzopyran-4-one, 7-[[2-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (S)-
- 4H-1-Benzopyran-4-one,7-[[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-,(2S)-
- 7-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-2,3-dihydrochromen-4-one